These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2954375)

  • 1. Pharmacokinetics of norethindrone oenanthate in 5 women after a single dose of norethindrone oenanthate and estradiol valerate.
    Sang GW; Liu XH
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):255-9. PubMed ID: 2954375
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
    Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
    Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral continuous and transdermal cyclic 17-beta estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women.
    Kaplan PB; Gücer F; Sayin NC; Yüce MA; Yardim T
    J Reprod Med; 2002 Aug; 47(8):651-5. PubMed ID: 12216432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of norethisterone oenanthate in humans.
    Sang GW; Fotherby K; Howard G; Elder M; Bye PG
    Contraception; 1981 Jul; 24(1):15-27. PubMed ID: 7273765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay of serum norethisterone oenanthate levels in women after intramuscular administration.
    Saxena BN; Shrimanker K; Fotherby K
    J Steroid Biochem; 1977 Oct; 8(10):1117-9. PubMed ID: 916668
    [No Abstract]   [Full Text] [Related]  

  • 8. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
    Stuedal A; Ma H; Bjørndal H; Ursin G
    Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
    Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
    J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.
    Panoulis C; Lambrinoudaki I; Vourtsi A; Augoulea A; Kaparos G; Aravantinos L; Christodoulakos G; Creatsas G
    Climacteric; 2009 Jun; 12(3):240-7. PubMed ID: 19387881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of progesterone and norethisterone oenanthate on dynamic distribution of progesterone receptor in target cell].
    Peng XR; Zou JC; Chang CY
    Sheng Li Xue Bao; 1987 Apr; 39(2):174-82. PubMed ID: 3659966
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction.
    Contraception; 1997 Oct; 56(4):193-207. PubMed ID: 9408700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
    Zimmermann H; Koytchev R; Mayer O; Börner A; Mellinger U; Breitbarth H
    Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of norethindrone in women. II. Single-dose kinetics.
    Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Rowe PH; Smith E
    Clin Pharmacol Ther; 1978 Oct; 24(4):448-53. PubMed ID: 688734
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
    Nakajima ST; Archer DF; Ellman H
    Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.
    Bortolotti de Mello Jacobucci MS; Guazzelli CA; Barbieri M; Araújo FF; Moron AF
    Contraception; 2006 Jun; 73(6):594-7. PubMed ID: 16730490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW; Gluck OS; Lang E; Rakov V
    Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-a-month injectable contraceptives.
    d'Arcangues C
    World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activelle - modern low-dose hormone replacement therapy for postmenopausal women].
    Novo Nordisk.
    Akush Ginekol (Sofiia); 2000; 39 Suppl 2():28-30. PubMed ID: 11188014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.